Stanley Korenman is an Endocrinology/Metabolic physician affiliated with University of California, Los Angeles. OpenAlex indexes 187 publications with 9,963 citations (h-index 52); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza
#365,530,420,120
Los Angeles, CA 90095
Telephone
310-825-7922Registry record last updated 28 Jun 2010.
Clinical trials
- Pharmacogenetics of Hypertriglyceridemia in Hispanics
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
57.6%l-Thyroxine37.3%Levothyroxine Sodium100%Part D≥13 patientsCalcium-sensing Receptor Agonist20.3%Cinacalcet Hcl100%Part D<11 patientsMetabolism & gastrointestinal
23.7%Biguanide (metformin)23.7%Metformin Hcl100%Part D<11 patientsGenitourinary & hormones
18.6%Androgen18.6%Testosterone Cypionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1985–2010 per NIH RePORTER. The latest:
- PHARMACOGENETICS OF HYPERTRIGLYCERIDEMIA IN HISPANICS
University of California Los Angeles
FY2010$21,755M01RR000865 - Phamracogenetics of Hypertriglyceridemia in Hispanics
University of California Los Angeles
FY2007$494,219R01HL076771 - Phamracogenetics of Hypertriglyceridemia in Hispanics
University of California Los Angeles
FY2006$504,920R01HL076771
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
The Journal of Clinical Endocrinology & Metabolism
2005 - Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
Journal of Psychiatry and Neuroscience
2004 - Reproductive Hormones in the Early Menopausal Transition: Relationship to Ethnicity, Body Size, and Menopausal Status
The Journal of Clinical Endocrinology & Metabolism
2003 - Depression in women with polycystic ovary syndrome: clinical and biochemical correlates
Journal of Affective Disorders
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”